173 related articles for article (PubMed ID: 12150333)
1. Absence of activating mutations in the hot spots of the LH receptor and Gs-alpha genes in Leydig cell tumors.
Vieira TC; Cerutti JM; Dias da Silva MR; Delcelo R; Abucham J
J Endocrinol Invest; 2002; 25(7):598-602. PubMed ID: 12150333
[TBL] [Abstract][Full Text] [Related]
2. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors.
Fragoso MC; Latronico AC; Carvalho FM; Zerbini MC; Marcondes JA; Araujo LM; Lando VS; Frazzatto ET; Mendonca BB; Villares SM
J Clin Endocrinol Metab; 1998 Jun; 83(6):2074-8. PubMed ID: 9626141
[TBL] [Abstract][Full Text] [Related]
3. No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors.
Giacaglia LR; Kohek MB da F; Carvalho FM; Fragoso MC; Mendonca B; Latronico AC
Fertil Steril; 2000 Nov; 74(5):992-5. PubMed ID: 11056247
[TBL] [Abstract][Full Text] [Related]
4. Peripheral precocious puberty in a male caused by Leydig cell adenoma harboring a somatic mutation of the LHR gene: report of a case.
Sangkhathat S; Kanngurn S; Jaruratanasirikul S; Tubtawee T; Chaiyapan W; Patrapinyokul S; Chiengkriwate P
J Med Assoc Thai; 2010 Sep; 93(9):1093-7. PubMed ID: 20873084
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors.
Canto P; Söderlund D; Ramón G; Nishimura E; Méndez JP
Am J Med Genet; 2002 Mar; 108(2):148-52. PubMed ID: 11857565
[TBL] [Abstract][Full Text] [Related]
6. Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor.
Richter-Unruh A; Wessels HT; Menken U; Bergmann M; Schmittmann-Ohters K; Schaper J; Tappeser S; Hauffa BP
J Clin Endocrinol Metab; 2002 Mar; 87(3):1052-6. PubMed ID: 11889161
[TBL] [Abstract][Full Text] [Related]
7. Sexual pseudo-precocity caused by a somatic activating mutation of the LH receptor preceding true sexual precocity.
Kiepe D; Richter-Unruh A; Autschbach F; Kessler M; Schenk JP; Bettendorf M
Horm Res; 2008; 70(4):249-53. PubMed ID: 18772599
[TBL] [Abstract][Full Text] [Related]
8. Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations.
Carvajal-Carmona LG; Alam NA; Pollard PJ; Jones AM; Barclay E; Wortham N; Pignatelli M; Freeman A; Pomplun S; Ellis I; Poulsom R; El-Bahrawy MA; Berney DM; Tomlinson IP
J Clin Endocrinol Metab; 2006 Aug; 91(8):3071-5. PubMed ID: 16757530
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the LH receptor gene in Leydig cell adenoma and hyperplasia and functional and biochemical studies of activating mutations of the LH receptor gene.
Boot AM; Lumbroso S; Verhoef-Post M; Richter-Unruh A; Looijenga LH; Funaro A; Beishuizen A; van Marle A; Drop SL; Themmen AP
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1197-205. PubMed ID: 21490077
[TBL] [Abstract][Full Text] [Related]
10. A single somatic activating Asp578His mutation of the luteinizing hormone receptor causes Leydig cell tumour in boys with gonadotropin-independent precocious puberty.
d'Alva CB; Brito VN; Palhares HM; Carvalho FM; Arnhold IJ; Mendonca BB; Latronico AC
Clin Endocrinol (Oxf); 2006 Sep; 65(3):408-10. PubMed ID: 16918965
[No Abstract] [Full Text] [Related]
11. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor.
Liu G; Duranteau L; Carel JC; Monroe J; Doyle DA; Shenker A
N Engl J Med; 1999 Dec; 341(23):1731-6. PubMed ID: 10580072
[No Abstract] [Full Text] [Related]
12. Luteinizing hormone receptor mutations in disorders of sexual development and cancer.
Wu SM; Leschek EW; Rennert OM; Chan WY
Front Biosci; 2000 Mar; 5():D343-52. PubMed ID: 10704433
[TBL] [Abstract][Full Text] [Related]
13. A constitutively active somatic mutation of the human lutropin receptor found in Leydig cell tumors activates the same families of G proteins as germ line mutations associated with Leydig cell hyperplasia.
Hirakawa T; Ascoli M
Endocrinology; 2003 Sep; 144(9):3872-8. PubMed ID: 12933660
[TBL] [Abstract][Full Text] [Related]
14. Leydig-cell tumour in children: variable clinical presentation, diagnostic features, follow-up and genetic analysis of four cases.
Petkovic V; Salemi S; Vassella E; Karamitopoulou-Diamantis E; Meinhardt UJ; Flück CE; Mullis PE
Horm Res; 2007; 67(2):89-95. PubMed ID: 17047343
[TBL] [Abstract][Full Text] [Related]
15. Leydig cell tumors in children: contrasting clinical, hormonal, anatomical, and molecular characteristics in boys and girls.
Olivier P; Simoneau-Roy J; Francoeur D; Sartelet H; Parma J; Vassart G; Van Vliet G
J Pediatr; 2012 Dec; 161(6):1147-52. PubMed ID: 22727875
[TBL] [Abstract][Full Text] [Related]
16. Direct luteinizing hormone action triggers adrenocortical tumorigenesis in castrated mice transgenic for the murine inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
Rilianawati ; Paukku T; Kero J; Zhang FP; Rahman N; Kananen K; Huhtaniemi I
Mol Endocrinol; 1998 Jun; 12(6):801-9. PubMed ID: 9626655
[TBL] [Abstract][Full Text] [Related]
17. Activating mutations of the lutropin choriogonadotropin receptor in precocious puberty.
Shenker A
Recept Channels; 2002; 8(1):3-18. PubMed ID: 12408104
[TBL] [Abstract][Full Text] [Related]
18. Venous sampling can be crucial in identifying the testicular origin of idiopathic male luteinising hormone-independent sexual precocity.
Richter-Unruh A; Jorch N; Wessels HT; Weber EA; Hauffa BP
Eur J Pediatr; 2002 Dec; 161(12):668-71. PubMed ID: 12447668
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral activating GNAS (R201C) mutation in two unrelated patients with virilizing ovarian Leydig cell tumors.
Bieler BM; Gerber SM; Pérez de Nanclares G; Hardisson D; Lecumberri B
Endocrinol Diabetes Nutr; 2017; 64(6):335-337. PubMed ID: 29056280
[No Abstract] [Full Text] [Related]
20. Gonadotropin-independent precocious puberty associated with a somatic activating mutation of the LH receptor gene: detection of a mutation present in only a small fraction of cells from testicular tissue using wild-type blocking polymerase chain reaction and laser-capture microdissection.
Goji K; Teraoka Y; Hosokawa Y; Okuno M; Ozaki K; Yoshida M; Matsuo M
Endocrine; 2009 Jun; 35(3):397-401. PubMed ID: 19280371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
